🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study was to assess the effect of gefitinib on...
Status
Unknown
Location
Sun Yat-Sen Univercity Cancer Center
Start Date
2020-05-26
Trial ID
NCT04390984
Treatments Being Tested
Pemetrexed was known to be effective to pulmonary adenocarcinoma and gefiti...
Status
Unknown
Location
Samsung Medical Center
Start Date
2008-05
Trial ID
NCT01066195
There are two different treatment modes for NSCLC patients who failed to ep...
Status
Unknown
Location
Department of Respiratory Medicne, Peking Union Medical Hospital
Start Date
2012-10
Trial ID
NCT01746277
Treatments Being Tested
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), in...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2016-05
Trial ID
NCT03050411
Treatments Being Tested
The purpose of this study is to assess the Treatment Strategies and Surviva...
Status
Recruiting
Location
Yongchang Zhang
Start Date
2020-04-16
Trial ID
NCT04322890
Treatments Being Tested
The purpose of this study is to determine whether metformin is effective in...
Status
Terminated
Location
National Cheng-Kung Uni. Hosp.
Start Date
2013-08
Trial ID
NCT01997775
Treatments Being Tested
The purpose of this study is to explore the activity of ZD1839 added to con...
Status
Completed
Location
The University of Chicago Medical Center
Start Date
2003-01-27
Trial ID
NCT01185171
Treatments Being Tested
This is a single arm phase II clinical trial, which aims to evaluate the ef...
Status
Unknown
Location
Department of Oncology, Shanghai pulmonary hospital
Start Date
2016-11
Trial ID
NCT02930954
Treatments Being Tested
Intercalated administration of Iressa® (gefitinib) on days 5-18 of chemothe...
Status
Unknown
Location
National Cancer Center
Start Date
2012-03
Trial ID
NCT01502202
Treatments Being Tested